Patents Assigned to Robugen GmbH, Pharmazeutische Fabrik
  • 5-ethyl-2-deoxyuridine and urea composition for the treatment of viral diseases
    Patent number: 4851391
    Abstract: Novel medicinal agent for the topical treatment of viral diseases, containing 5-ethyl-2'-deoxyuridine as the antivirally active compound and urea as the penetration-promoting compound, in an aqueous gel.
    Type: Grant
    Filed: February 26, 1988
    Date of Patent: July 25, 1989
    Assignee: ROBUGEN GmbH Pharmazeutische Fabrik
    Inventors: Bernd Hempel, Ravindernath Kaul
  • Novel monophosphates
    Patent number: 4271153
    Abstract: Novel 5-lower alkyl-2'-desoxyuridine-5'-monophosphates of the formula ##STR1## wherein R is lower alkyl of 2 to 6 carbon atoms having antiviral activity.
    Type: Grant
    Filed: April 17, 1979
    Date of Patent: June 2, 1981
    Assignee: Robugen GmbH Pharmazeutische Fabrik
    Inventor: Kailash K. Gauri
  • Fungicidally active uracil derivatives
    Patent number: 4017626
    Abstract: Uracil derivatives having the general formula: ##STR1## wherein R.sub.1 and R.sub.3 are each an alkyl group of 2 to 10 carbon atoms or an alkenyl group of 3 to 10 carbon atoms, R.sub.5 is an alkyl group of 2 to 5 carbon atoms and X is a hydrogen or halogen atom. These compounds are characterized by their fungicidal activity.
    Type: Grant
    Filed: January 14, 1975
    Date of Patent: April 12, 1977
    Assignee: Robugen GmbH, Pharmazeutische Fabrik
    Inventor: Kailash Kumar Gauri